A possible participation of transient receptor potential vanilloid type 1 channels in the antidepressant effect of fluoxetine

European Journal of Pharmacology

Volumn 685, Issue 1-3, 2012, Pages 81-90

  Manna, Shyamshree S S ^a   Umathe, Sudhir N ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

Capsaicin; Capsazepine; Forced swim test; Glutamate; N methyl d aspartate; Serotonin

Indexed keywords

CAPSAICIN; CAPSAZEPINE; FENCLONINE; FLUOXETINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG RESPONSE; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CAPSAICIN; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FENCLONINE; FLUOXETINE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; SEROTONIN; SWIMMING; TRPV CATION CHANNELS;

EID: 84861346968     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.023     Document Type: Article

References (50)

1. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, P.F. Cheng, E.T. Kavalali, and L.M. Monteggia NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 2011 91 95
2. I.V. Belozertseva, T. Kos, P. Popik, W. Danysz, and A.Y. Bespalov Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests Eur. Neuropsychopharmacol. 17 2007 172 179
3. R.J. Bodnar, A. Kirchgessner, G. Nilaver, J. Mulhern, and E.A. Zimmerman Intraventricular capsaicin: alterations in analgesic responsivity without depletion of substance P Neuroscience 7 1982 631 638
4. M.J. Caterina, A. Leffler, A.B. Malmberg, W.J. Martin, J. Trafton, K.R. Petersen-Zeitz, M. Koltzenburg, A.I. Basbaum, and D. Julius Impaired nociception and pain sensation in mice lacking the capsaicin receptor Science 288 2000 306 313
5. L. Cristino, L. de Petrocellis, G. Pryce, D. Baker, V. Guglielmotti, and V. Di Marzo Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain Neuroscience 139 2006 1405 1415
6. M. Ghasemi, M. Raza, and A.R. Dehpour NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test J. Psychopharmacol. 24 2010 585 594
7. T. Hayase Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors BMC Pharmacol. 11 2011 6
8. A.G. Hayes, M. Skingle, and M.B. Tyers Effects of single doses of capsaicin on nociceptive thresholds in the rodent Neuropharmacology 20 1981 505 511
9. A. Jancso-Gabor, J. Szolcsanyi, and N. Jancso Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in rats and guinea-pigs J. Physiol. 206 1970 495 507
10. Y.H. Jin, T.W. Bailey, B.Y. Li, J.H. Schild, and M.C. Andresen Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals in nucleus tractus solitarius J. Neurosci. 24 2004 4709 4717
11. J. Karasawa, T. Shimazaki, N. Kawashima, and S. Chaki AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist Brain Res. 1042 2005 92 98
12. J.W. Kasckow, J.J. Mulchahey, and T.D. Geracioti Jr. Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2004 291 295
13. N. Kawashima, J. Karasawa, T. Shimazaki, S. Chaki, S. Okuyama, A. Yasuhara, and A. Nakazato Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors Neurosci. Lett. 378 2005 131 134
14. N. Khairatkar-Joshi, and A. Szallasi TRPV1 antagonists: the challenges for therapeutic targeting Trends Mol. Med. 15 2009 14 22
15. J.S. Kim, W. Schmid-Burgk, D. Claus, and H.H. Kornhuber Increased serum glutamate in depressed patients Arch. Psychiatr. Nervenkr. 232 1982 299 304
16. K.M. Kim, T. Kawada, K. Ishihara, K. Inoue, and T. Fushiki Inhibition by a capsaicin antagonist (capsazepine) of capsaicin-induced swimming capacity increase in mice Biosci. Biotechnol. Biochem. 62 1998 2444 2445
17. S. Laínez, P. Valente, I. Ontoria-Oviedo, J. Estévez- Herrera, M. Camprubí-Robles, A. Ferrer-Montiel, and R. Planells-Cases GABAA receptor associated protein (GABARAP) modulates TRPV1 expression and channel function and desensitization FASEB J. 24 2010 1958 1970
18. R.H. LaMotte, C.N. Shain, D.A. Simone, and E.F. Tsai Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms J. Neurophysiol. 66 1991 190 211
19. R.H. LaMotte, L.E. Lundberg, and H.E. Torebjork Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin J. Physiol. 448 1992 749 764
20. J. Lee, V. Di Marzo, and J.M. Brotchie A role for vanilloid receptor 1 (TRPV1) and endocannabinoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats Neuropharmacology 51 2006 557 565
21. D.P. Li, S.R. Chen, and H.L. Pan VR1 receptor activation induces glutamate release and postsynaptic firing in the paraventricular nucleus J. Neurophysiol. 92 2004 1807 1816
22. H.B. Li, R.R. Mao, J.C. Zhang, Y. Yang, J. Cao, and L. Xu Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory Biol. Psychiatry 64 2008 286 292
23. D.R. Loyd, P.B. Chen, and K.M. Hargreaves Anti-hyperalgesic effects of anti-serotonergic compounds on serotonin- and capsaicin-evoked thermal hyperalgesia in the rat Neuroscience 203 2012 207 215
24. M. Maes, R. Verkerk, E. Vandoolaeghe, A. Lin, and S. Scharpé Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity Acta Psychiatr. Scand. 97 1998 302 308
25. R. Marsch, E. Foeller, G. Rammes, M. Bunck, M. Kossl, F. Holsboer, W. Zieglgansberger, R. Landgraf, B. Lutz, and C.T. Wotjak Reduced anxiety, conditioned fear, and hippocampal longterm potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice J. Neurosci. 27 2007 832 839
26. S. McGaraughty, K.L. Chu, R.S. Bitner, B. Martino, R. El Kouhen, P. Han, A.L. Nikkel, E.C. Burgard, C.R. Faltynek, and M.F. Jarvis Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM J. Neurophysiol. 90 2003 2702 2710
27. E. Mezey, Z.E. Tóth, D.N. Cortright, M.K. Arzubi, J.E. Krause, R. Elde, A. Guo, P.M. Blumberg, and A. Szallasi Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human Proc. Natl. Acad. Sci. U. S. A. 97 2000 3655 3660
28. T. Ohta, Y. Ikemi, M. Murakami, T. Imagawa, K. Otsuguro, and S. Ito Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons J. Physiol. 576 2006 809 822
29. E. Palazzo, V. de Novellis, I. Marabese, D. Cuomo, F. Rossi, L. Berrino, F. Rossi, and S. Maione Interaction between vanilloid and glutamate receptors in the central modulation of nociception Eur. J. Pharmacol. 439 2002 69 75
30. G. Paxinos, and R.B.J. Franklin The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego
31. A. Pilc, S. Chaki, G. Nowak, and J.M. Witkin Mood disorders: regulation by metabotropic glutamate receptors Biochem. Pharmacol. 75 2008 997 1006
32. L. Pomierny-Chamioło, E. Poleszak, A. Pilc, and G. Nowak NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice Pharmacol. Rep. 62 2010 1186 1190
33. J.C. Roberts, J.B. Davis, and C.D. Benham [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution Brain Res. 995 2004 176 183
34. A.A. Romanovsky, M.C. Almeida, A. Garami, A.A. Steiner, M.H. Norman, S.F. Morrison, K. Nakamura, J.J. Burmeister, and T.B. Nucci The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not Pharmacol. Rev. 61 2009 228 261
35. T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Vigano, E. Marras, S. Petrosino, G. Perletti, M. Maccarrone, V. Di Marzo, and D. Parolaro Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb. Cortex 18 2008 1292 1301
36. T. Sakurada, T. Matsumura, T. Moriyama, C. Sakurada, S. Ueno, and S. Sakurada Differential effects of intraplantar capsazepine and ruthenium red on capsaicin-induced desensitization in mice Pharmacol. Biochem. Behav. 75 2003 115 121
37. T. Sasamura, M. Sasaki, C. Tohda, and Y. Kuraishi Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus Neuroreport 9 1998 2045 2048
38. K. Starowicz, S. Maione, L. Cristino, E. Palazzo, I. Marabese, F. Rossi, V. de Novellis, and V. Di Marzo Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways J. Neurosci. 27 2007 13739 13749
39. K. Starowicz, S. Nigam, and V. Di Marzo Biochemistry and pharmacology of endovanilloids Pharmacol. Ther. 114 2007 13 33
40. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370
41. A. Szallasi, and P.M. Blumberg Vanilloid (Capsaicin) receptors and mechanisms Pharmacol. Rev. 51 1999 159 212
42. A. Szallasi, and V. Di Marzo New perspectives on enigmatic vanilloid receptors Trends Neurosci. 23 2000 491 497
43. A.L. Terzian, D.C. Aguiar, F.S. Guimarães, and F.A. Moreira Modulation of anxiety-like behaviour by transient receptor potential vanilloid type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray Eur. Neuropsychopharmacol. 19 2009 188 195
44. A. Tóth, J. Boczán, N. Kedei, E. Lizanecz, Z. Bagi, Z. Papp, I. Edes, L. Csiba, and P.M. Blumberg Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain Brain Res. Mol. Brain Res. 135 2005 162 168
45. S.N. Umathe, P.S. Bhutada, N.S. Jain, N.R. Shukla, Y.R. Mundhada, and P.V. Dixit Gonadotropin releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice Neuropeptides 42 2008 399 410
46. S.N. Umathe, J.M. Vaghasiya, N.S. Jain, and P.V. Dixit Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1161 1166
47. 2 + channels Synapse 48 2003 170 177
48. K.A. Wardle, J. Ranson, and G.J. Sanger Pharmacological characterization of the vanilloid receptor in the rat dorsal horn Br. J. Pharmacol. 121 1997 1012 1016
49. I.J. You, Y.H. Jung, M.J. Kim, S.H. Kwon, S.I. Hong, S.Y. Lee, and C.G. Jang Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HT(1A), GABA(A), and NMDA receptors Neuropharmacology 62 2012 1034 1043
50. K. Zavitsanou, V.S. Dalton, H. Wang, P. Newson, and L.A. Chahl Receptor changes in brain tissue of rats treated as neonates with capsaicin J. Chem. Neuroanat. 39 2010 248 255